# Defilade Capital Management, L.P.: Form 13F holdings

An institutional investment manager in EMERYVILLE, CA. SEC CIK 2088557.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $746.9m
- Positions: 39 (39 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/2088557/000208855726000008/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ELI LILLY & CO (LLY)](/companies/lly.md) | COM | $46.9m | 6.3% | 39,086 |  | Added +18,390 |
| [PFIZER INC (PFE)](/companies/pfe.md) | COM | $42.7m | 5.7% | 1,771,743 |  | Added +307,614 |
| [VEEVA SYS INC (VEEV)](/companies/veev.md) | CL A COM | $42.0m | 5.6% | 236,709 |  | New +236,709 |
| [BIOMARIN PHARMACEUTICAL INC (BMRN)](/companies/bmrn.md) | COM | $39.0m | 5.2% | 682,005 |  | New +682,005 |
| [PTC THERAPEUTICS INC (PTCT)](/companies/ptct.md) | COM | $35.4m | 4.7% | 433,699 |  | Added +57,534 |
| [BAXTER INTL INC (BAX)](/companies/bax.md) | COM | $31.1m | 4.2% | 1,459,380 |  | New +1,459,380 |
| [INSMED INC (INSM)](/companies/insm.md) | COM PAR $.01 | $30.0m | 4.0% | 281,838 |  | Added +86,929 |
| [ZIMMER BIOMET HOLDINGS INC (ZBH)](/companies/zbh.md) | COM | $27.3m | 3.7% | 317,426 |  | Reduced −261,735 |
| [INSULET CORP (PODD)](/companies/podd.md) | COM | $26.9m | 3.6% | 176,932 |  | New +176,932 |
| [THERMO FISHER SCIENTIFIC INC (TMO)](/companies/tmo.md) | COM | $26.0m | 3.5% | 51,934 |  | New +51,934 |
| [ABBOTT LABORATORIES (ABT)](/companies/abt.md) | COM | $25.9m | 3.5% | 285,778 |  | New +285,778 |
| ASCENDIS PHARMA A/S | ORD SHS | $25.3m | 3.4% | 94,843 |  | New +94,843 |
| [SOLVENTUM CORP (SOLV)](/companies/solv.md) | COM SHS | $24.4m | 3.3% | 316,454 |  | New +316,454 |
| MEDTRONIC PLC | SHS | $23.7m | 3.2% | 303,301 |  | New +303,301 |
| [ELANCO ANIMAL HEALTH INC (ELAN)](/companies/elan.md) | COM | $21.3m | 2.8% | 864,080 |  | Reduced −67,041 |
| [AGIOS PHARMACEUTICALS INC (AGIO)](/companies/agio.md) | COM | $20.3m | 2.7% | 546,848 |  | New +546,848 |
| [ENVISTA HOLDINGS CORPORATION (NVST)](/companies/nvst.md) | COM | $19.1m | 2.6% | 726,108 |  | New +726,108 |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $15.5m | 2.1% | 82,827 |  | Reduced −233,145 |
| [ICU MED INC (ICUI)](/companies/icui.md) | COM | $15.5m | 2.1% | 105,700 |  | Reduced −148,591 |
| [COGENT BIOSCIENCES INC (COGT)](/companies/cogt.md) | COM | $15.2m | 2.0% | 393,441 |  | Added +40,851 |
| [LANTHEUS HLDGS INC (LNTH)](/companies/lnth.md) | COM | $14.7m | 2.0% | 132,662 |  | Reduced −116,739 |
| [OCULAR THERAPEUTIX INC (OCUL)](/companies/ocul.md) | COM | $14.6m | 2.0% | 1,490,286 |  | Added +2,641 |
| [ELEDON PHARMACEUTICALS INC (ELDN)](/companies/eldn.md) | COM | $13.9m | 1.9% | 3,525,338 |  | Reduced −38,789 |
| [TYRA BIOSCIENCES INC (TYRA)](/companies/tyra.md) | COM | $12.0m | 1.6% | 376,870 |  | New +376,870 |
| [OLEMA PHARMACEUTICALS INC (OLMA)](/companies/olma.md) | COM | $11.6m | 1.5% | 924,758 |  | Reduced −579,778 |
| [ORIC PHARMACEUTICALS INC (ORIC)](/companies/oric.md) | COM | $11.3m | 1.5% | 1,047,690 |  | Added +204,762 |
| [LARIMAR THERAPEUTICS INC (LRMR)](/companies/lrmr.md) | COM | $11.2m | 1.5% | 3,670,135 |  | New +3,670,135 |
| [GLOBUS MED INC (GMED)](/companies/gmed.md) | CL A | $11.0m | 1.5% | 139,637 |  | Reduced −214,713 |
| [ENOVIS CORPORATION (ENOV)](/companies/enov.md) | COM | $11.0m | 1.5% | 531,945 |  | New +531,945 |
| [EVOMMUNE INC (EVMN)](/companies/evmn.md) | COM SHS | $10.5m | 1.4% | 793,145 |  | Added +114,556 |
| [TELEFLEX INCORPORATED (TFX)](/companies/tfx.md) | COM | $10.2m | 1.4% | 80,118 |  | New +80,118 |
| [DENALI THERAPEUTICS INC (DNLI)](/companies/dnli.md) | COM | $10.1m | 1.3% | 391,866 |  | Reduced −968,103 |
| [GLAUKOS CORP (GKOS)](/companies/gkos.md) | COM | $9.3m | 1.2% | 66,519 |  | New +66,519 |
| [STAAR SURGICAL CO (STAA)](/companies/staa.md) | COM PAR $0.01 | $9.2m | 1.2% | 322,126 |  | New +322,126 |
| [PACS GROUP INC (PACS)](/companies/pacs.md) | COM SHS | $9.2m | 1.2% | 215,675 |  | Reduced −388,505 |
| CRINETICS PHARMACEUTICALS IN | COM | $9.0m | 1.2% | 239,440 |  | New +239,440 |
| LIVANOVA PLC | SHS | $8.8m | 1.2% | 107,373 |  | New +107,373 |
| [BLACK DIAMOND THERAPEUTICS I (BDTX)](/companies/bdtx.md) | COM | $3.1m | 0.4% | 1,674,999 |  | New +1,674,999 |
| [MEREO BIOPHARMA GROUP PLC (MREO)](/companies/mreo.md) | SPON ADS | $2.4m | 0.3% | 7,558,756 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ALIGN TECHNOLOGY INC (ALGN)](/companies/algn.md) | COM | $0 | 0.0% | 0 |  | Sold out −67,332 |
| ASCENDIS PHARMA A/S | SPONSORED ADR | $0 | 0.0% | 0 |  | Sold out −51,895 |
| [BECTON DICKINSON & CO (BDX)](/companies/bdx.md) | COM | $0 | 0.0% | 0 |  | Sold out −279,210 |
| [BIOGEN INC (BIIB)](/companies/biib.md) | COM | $0 | 0.0% | 0 |  | Sold out −96,289 |
| BIOHAVEN LTD | COM | $0 | 0.0% | 0 |  | Sold out −315,944 |
| [DEXCOM INC (DXCM)](/companies/dxcm.md) | COM | $0 | 0.0% | 0 |  | Sold out −538,762 |
| [INTEGER HLDGS CORP (ITGR)](/companies/itgr.md) | COM | $0 | 0.0% | 0 |  | Sold out −213,027 |
| [INTUITIVE SURGICAL INC (ISRG)](/companies/isrg.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −67,681 |
| [NEUROCRINE BIOSCIENCES INC (NBIX)](/companies/nbix.md) | COM | $0 | 0.0% | 0 |  | Sold out −209,932 |
| NUVALENT INC | COM | $0 | 0.0% | 0 |  | Sold out −129,950 |
| [SCHEIN HENRY INC (HSIC)](/companies/hsic.md) | COM | $0 | 0.0% | 0 |  | Sold out −624,037 |
| [TANDEM DIABETES CARE INC (TNDM)](/companies/tndm.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −761,905 |

Source: SEC EDGAR, Form 13F-HR, accession 0002088557-26-000008. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.